This inventor holds 1 USPTO granted patent. Top assignee: Université Libre De Bruxelles. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Emmanuel Bartholomé: Innovator in Dendritic Cell Research
Introduction
Emmanuel Bartholomé is a notable inventor based in Wemmel, Belgium. He has made significant contributions to the field of immunology, particularly in the generation and use of dendritic cells. His innovative work has implications for various therapeutic applications.
Latest Patents
Bartholomé holds a patent for an in vitro method for the differentiation and maturation of isolated monocytes into IL3-R+CD11c+ myeloid dendritic cells. This method involves incubating the monocytes with a combination of a type I interferon and IL-3. His patent represents a crucial advancement in the understanding and manipulation of immune responses.
Career Highlights
Emmanuel Bartholomé is affiliated with the Université Libre de Bruxelles, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to enhance immunotherapy strategies and improve patient outcomes.
Collaborations
Bartholomé has collaborated with esteemed colleagues such as Michel Goldman and Christel Buelens. These partnerships have enriched his research and contributed to the advancement of knowledge in the field of dendritic cell biology.
Conclusion
Emmanuel Bartholomé's contributions to dendritic cell research exemplify the impact of innovative thinking in the scientific community. His work not only advances our understanding of immune mechanisms but also paves the way for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile